
Formats: [HTML](/news/2012/09/7/cipla-does-not-infringe-a-valid-roche-patent-on-erlotinib-trade-name-tarceva-for-the-production-of-its-generic-cancer-drug-erlocip-says.html)  [JSON](/news/2012/09/7/cipla-does-not-infringe-a-valid-roche-patent-on-erlotinib-trade-name-tarceva-for-the-production-of-its-generic-cancer-drug-erlocip-says.json)  [XML](/news/2012/09/7/cipla-does-not-infringe-a-valid-roche-patent-on-erlotinib-trade-name-tarceva-for-the-production-of-its-generic-cancer-drug-erlocip-says.xml)  

### [2012-09-7](/news/2012/09/7/index.md)

##### Cipla
# Cipla does not infringe a valid Roche patent on erlotinib (trade name "Tarceva") for the production of its generic cancer drug Erlocip, says the Delhi High Court. 




### Sources:

1. [LiveMint](http://www.livemint.com/2012/09/07222230/Cipla-wins-patent-case-over-Ta.html?atype=tp)
2. [Reuters](http://in.reuters.com/article/2012/09/07/india-roche-cipla-idINL4E8K73UQ20120907)
2. [Cover Image](http://s4.reutersmedia.net/resources_v2/images/rcom-default.png)

### Changes:

1. [Cipla does not infringe a valid Roche patent on erlotinib (trade name ''Tarceva'') for the production of its generic cancer drug Erlocip, says the Delhi High Court. ](/news/2012/09/7/cipla-does-not-infringe-a-valid-roche-patent-on-erlotinib-trade-name-tarceva-for-the-production-of-its-generic-cancer-drug-erlocip-sa.md) _2018-02-06 13:49:24 (First version)_
1. [Cipla does not infringe a valid Roche patent on erlotinib (trade name "Tarceva") for the production of its generic cancer drug Erlocip, says the Delhi High Court. ](/news/2012/09/7/cipla-does-not-infringe-a-valid-roche-patent-on-erlotinib-trade-name-tarceva-for-the-production-of-its-generic-cancer-drug-erlocip-says.md) _(Current version)_

### Related:

1. [Swiss drugmaker Hoffmann-La Roche agrees to acquire American drugmaker InterMune for $8.3 billion. ](/news/2014/08/24/swiss-drugmaker-hoffmann-la-roche-agrees-to-acquire-american-drugmaker-intermune-for-8-3-billion.md) _Context: Hoffmann-La Roche_
2. [The U.S. Food and Drug Administration (FDA) approves Kadcyla, a new drug manufactured by Roche, for treating late-stage breast cancer. ](/news/2013/02/22/the-u-s-food-and-drug-administration-fda-approves-kadcyla-a-new-drug-manufactured-by-roche-for-treating-late-stage-breast-cancer.md) _Context: Hoffmann-La Roche_
3. [Delhi High Court acquits three accused in a 1984 anti-Sikh riots case at Shastri Nagar in North Delhi following the assassination of Prime Minister Indira Gandhi on October 31, 1984. ](/news/2010/05/21/delhi-high-court-acquits-three-accused-in-a-1984-anti-sikh-riots-case-at-shastri-nagar-in-north-delhi-following-the-assassination-of-prime-m.md) _Context: Delhi High Court_
4. [ A 148-year-old colonial law banning homosexual intercourse in India is overturned by the High Court in New Delhi. ](/news/2009/07/2/a-148-year-old-colonial-law-banning-homosexual-intercourse-in-india-is-overturned-by-the-high-court-in-new-delhi.md) _Context: Delhi High Court_
